Yu U. Ogino
Omorinaka, 1438541, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Pemafibrate therapy increases serum zinc levels in patients with metabolic dysfunction-associated steatohepatitis: a prospective study.
Journal: BMC gastroenterology
Published: February 17, 2026
Clinical Utility of Tremelimumab/Durvalumab as First-line Treatment for Unresectable Hepatocellular Carcinoma: Serum Cytokine Profile Insights.
Journal: Anticancer research
Published: November 19, 2025
The Bubble-Destruction Curve Obtained Using Contrast-Enhanced Ultrasound is Useful for Assessing Liver Fibrosis and Identifying At-risk MASH in Patients With MASLD.
Journal: Ultrasound in medicine & biology
Published: June 17, 2025
The Usefulness of Serum Interleukin-6 as a Predictor of Response to Atezolizumab plus Bevacizumab Combination Treatment in Hepatocellular Carcinoma.
Journal: Oncology
Published: May 30, 2024
Remaining Issues Related to Serum Cytokines in Patients with Unresectable Hepatocellular Carcinoma Treated by Atezolizumab plus Bevacizumab Combination Treatment.
Journal: Oncology
Published: January 06, 2024
Measurement of skeletal muscle volume is useful for predicting prognosis in patients with liver cirrhosis.
Journal: European journal of gastroenterology & hepatology
Published: September 28, 2022
Comparison of strain elastography and shear wave elastography in diagnosis of fibrosis in nonalcoholic fatty liver disease.
Journal: Journal of medical ultrasonics (2001)
Published: August 03, 2022
Lenvatinib Might Induce Activation of Host Immunity in Patients with Hepatocellular Carcinoma.
Journal: Oncology
Published: July 29, 2022
Usefulness of partial splenic embolization for left-sided portal hypertension in a patient with a pancreatic neuroendocrine neoplasm: a case report and review of the literature.
Journal: Clinical journal of gastroenterology
Published: November 09, 2021
Adaptation of lenvatinib treatment in patients with hepatocellular carcinoma and portal vein tumor thrombosis.
Journal: Cancer chemotherapy and pharmacology
Published: May 19, 2021
The ultrasound-guided attenuation parameter is useful in quantification of hepatic steatosis in non-alcoholic fatty liver disease.
Journal: JGH open : an open access journal of gastroenterology and hepatology
Published: February 22, 2021
Last Updated: 09/26/2026